Teleflex Completes Enrollment in Coronary Scaffold Trial
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has completed enrollment of 102 patients in a European clinical study evaluating longer versions of its dissolvable magnesium coronary scaffold, advancing research into …
Teleflex Completes Enrollment in Coronary Scaffold Trial Read More